Australia TGA ARTG recordElectronic insulin pen
Australia TGA ARTG Registered Device · Pfizer Australia Pty Ltd · PHC Corporation · Class IIa · Started November 19, 2021
Good Name: Pfizer Australia Pty Ltd - Electronic insulin pen
- Risk Class
- Class IIa
- Product Type
- Single Device Product
- ARTG Category
- General
- Start Date
- November 19, 2021
- Effective Date
- November 19, 2021
- Name
- PHC Corporation
- Country
- Japan
- Address
- 2131-1 Minamigata Toon, Ehime, 791-0395
This device is an electrical, auto-injector that is used with a dedicated Dose Dispenser Cartridge (DDC) under a home healthcare environment. The injector is for the self-injection of a subcutaneous dose of Tumor-Necrosis Factor inhibitors in the DDC. Patients are separately prescribed the DDC by healthcare professionals.
Access comprehensive regulatory information for Electronic insulin pen in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Pfizer Australia Pty Ltd, manufactured by PHC Corporation in Japan. The device registration started on November 19, 2021.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.